Literature DB >> 2563168

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

C Cordon-Cardo1, J P O'Brien, D Casals, L Rittman-Grauer, J L Biedler, M R Melamed, J R Bertino.   

Abstract

Endothelial cells of human capillary blood vessels at the blood-brain and other blood-tissue barrier sites express P-glycoprotein as detected by mouse monoclonal antibodies against the human multidrug-resistance gene product. This pattern of endothelial cell expression may indicate a physiological role for P-glycoprotein in regulating the entry of certain molecules into the central nervous system and other anatomic compartments, such as the testes. These tissues, which limit the access of systemic drugs, are known pharmacologic sanctuaries for metastatic cancer. P-glycoprotein expression in capillary endothelium of brain and testes and not other tissues (i.e., kidney and placenta) may in part explain this phenomenon and could have important implications in cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563168      PMCID: PMC286540          DOI: 10.1073/pnas.86.2.695

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Ultrastructure of the human dermal microcirculation: the horizontal plexus of the papillary dermis.

Authors:  A Yen; I M Braverman
Journal:  J Invest Dermatol       Date:  1976-03       Impact factor: 8.551

2.  Pharmacokinetics of actinoymcin D in patients with malignant melanoma.

Authors:  M H Tattersall; J E Sodergren; S K Dengupta; D H Trites; E J Modest; E Frei
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

3.  Chemotherapy of experimental metastatic brain tumors in female Wistar rats.

Authors:  H Hasegawa; W R Shapiro; J B Posner
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

4.  The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium.

Authors:  M Dym; D W Fawcett
Journal:  Biol Reprod       Date:  1970-12       Impact factor: 4.285

Review 5.  The blood-brain barrier to proteins under normal and pathological conditions.

Authors:  M W Brightman; I Klatzo; Y Olsson; T S Reese
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

6.  Ultrastructure of the human dermal microcirculation. II. The capillary loops of the dermal papillae.

Authors:  I M Braverman; A Yen
Journal:  J Invest Dermatol       Date:  1977-01       Impact factor: 8.551

7.  Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.

Authors:  N T Bech-Hansen; J E Till; V Ling
Journal:  J Cell Physiol       Date:  1976-05       Impact factor: 6.384

8.  Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment patient characteristics and treatment. A report for Childrens Cancer Study Group.

Authors:  M E Nesbit; L L Robison; J A Ortega; H N Sather; M Donaldson; D Hammond
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

9.  The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

Authors:  A E Evans; E S Gilbert; R Zandstra
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

10.  Pharmacokinetics of vincristine in the cerebrospinal fluid of humans.

Authors:  D V Jackson; V S Sethi; C L Spurr; J M McWhorter
Journal:  Cancer Res       Date:  1981-04       Impact factor: 12.701

View more
  390 in total

Review 1.  Determinants of passive drug entry into the central nervous system.

Authors:  M D Habgood; D J Begley; N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Liposome-mediated therapy of intracranial brain tumors in a rat model.

Authors:  U S Sharma; A Sharma; R I Chau; R M Straubinger
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

Review 4.  Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-05-31

Review 5.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.

Authors:  Elke Störmer; Lisa L von Moltke; Michael D Perloff; David J Greenblatt
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

7.  Effect of hemorrhagic shock on apoptosis and energy-dependent efflux system in the brain.

Authors:  Zhao-Ying Yu; Shinsuke Ono; Maria Spatz; Richard M McCarron
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

8.  Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers.

Authors:  David J Brayden; Joanna Griffin
Journal:  Vet Res Commun       Date:  2007-06-20       Impact factor: 2.459

Review 9.  Multidrug resistance in cancer chemotherapy.

Authors:  N H Patel; M L Rothenberg
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

10.  Identification of the distance between the homologous halves of P-glycoprotein that triggers the high/low ATPase activity switch.

Authors:  Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.